TrialThe Journal of clinical investigation2020

Sleeping Beauty-engineered CAR T cells achieve antileukemic activity without severe toxicities.

Chiara F Magnani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.